Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

ClinicalTrials.gov ID: NCT03954834

Public ClinicalTrials.gov record NCT03954834. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 7:27 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Three Tirzepatide Doses Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled With Diet and Exercise Alone

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal for this study is to evaluate the efficacy and safety of tirzepatide versus placebo in participants with type 2 diabetes not under control with diet and exercise alone. The study will last approximately 47 weeks and may include about 15 visits.

Study identification

NCT ID
NCT03954834
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
478 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 3, 2019 (Actual)
Primary completion
Oct 5, 2020 (Actual)
Completion
Oct 28, 2020 (Actual)
Last update posted
Oct 20, 2021

2019 – 2020

United States locations

U.S. sites
28
U.S. states
11
U.S. cities
27
Facility City State ZIP Site status
National Research Institute Huntington Park California 90255 —
National Research Institute Los Angeles California 90057 —
Catalina Research Institute, LLC Montclair California 91763 —
Valley Clinical Trials, Inc. Northridge California 91325 —
National Research Institute Panorama City California 91402 —
Southern California Dermatology Santa Ana California 92701 —
Clinical Research of South Florida Coral Gables Florida 33134 —
Encore Medical Research, LLC Hollywood Florida 33021 —
Axcess Medical Research Loxahatchee Groves Florida 33470 —
South Florida Wellness & Clinical Research Institute Margate Florida 33063 —
Suncoast Research Group, LLC Miami Florida 33135 —
Agile Clinical Research Trials Atlanta Georgia 30328 —
Sky Clinical Research Network Atlanta Georgia 30331 —
Cotton O'Neil Clinic Topeka Kansas 66606 —
Clinical Research Professionals Chesterfield Missouri 63005 —
StudyMetrix Research, LLC City of Saint Peters Missouri 63303 —
Aventiv Research Columbus Ohio 43213 —
Intend Research Norman Oklahoma 73069 —
The Corvallis Clinic P.C. Corvallis Oregon 97330 —
Heritage Valley Medical Group, Inc. Beaver Pennsylvania 15009 —
Family Medical Associates Levittown Pennsylvania 19056 —
Preferred Primary Care Physicians Pittsburgh Pennsylvania 15236 —
Preferred Primary Care Physicians Uniontown Pennsylvania 15401 —
Dallas Diabetes Endocrine Center Dallas Texas 75230 —
Clinical Trials of Texas, Inc. San Antonio Texas 78229 —
Consano Clinical Research Shavano Park Texas 78231 —
Capital Clinical Research Center Olympia Washington 98502 —
Rockwood Clinic Research Center Spokane Washington 99220 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03954834, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 20, 2021 · Synced Nov 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03954834 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →